Potential for Use of Species in the Subfamily Erynioideae for Biological Control and Biotechnology

Abstract

The fungal order Entomophthorales in the Zoopagomycota includes many fungal pathogens of arthropods. This review explores six genera in the subfamily Erynioideae within the family Entomophthoraceae, namely, Erynia, Furia, Orthomyces, Pandora, Strongwellsea, and Zoophthora. This is the largest subfamily in the Entomophthorales, including 126 described species. The species diversity, global distribution, and host range of this subfamily are summarized. Relatively few taxa are geographically widespread, and few have broad host ranges, which contrasts with many species with single reports from one location and one host species. The insect orders infected by the greatest numbers of species are the Diptera and Hemiptera. Across the subfamily, relatively few species have been cultivated in vitro, and those that have require more specialized media than many other fungi. Given their potential to attack arthropods and their position in the fungal evolutionary tree, we discuss which species might be adopted for biological control purposes or biotechnological innovations. Current challenges in the implementation of these species in biotechnology include the limited ability or difficulty in culturing many in vitro, a correlated paucity of genomic resources, and considerations regarding the host ranges of different species.

Transcriptomic Profiling of Bean Aphid Megoura crassicauda upon Exposure to the Aphid-Obligate Entomopathogen Conidiobolus obscurus (Entomophthoromycotina) and Screening of CytCo-Binding Aphid Proteins through a Pull-Down Assay

“…Some entomophthoralean fungi, such as Entomophaga aulicae which infects caterpillars, inhibit the activities of fungal glucan and chitin synthase, enabling rapid protoplast growth within the host and evading immune detection [ 3 ]. Their specialized nature may shorten periods of lethal infection through tailored adaptation to specific hosts, optimizing resource utilization and immune evasion strategies [ 13 ], yet the genomic intricacies of these specialist pathogens remain underexplored [ 14 , 15 , 16 ].…”